Applicability, safety and efficiency of outpatient treatment in uncomplicated diverticulitis.

BACKGROUND: In most cases of diverticulitis, inflammation is mild, and the only treatment required is a clear liquid diet and antibiotics. Until recently, patients were given this treatment as inpatients with the consequent expenditure of resources. The aim of this study was to assess the safety and efficacy of an outpatient treatment protocol with oral antibiotics in selected patients with uncomplicated acute diverticulitis in comparison with inpatient intravenous treatment. METHODS: We conducted a prospective non-randomized study between January 2007 and December 2009. We included all patients diagnosed with uncomplicated acute diverticulitis, at the Emergency Department of the University General Hospital of Elche. We compared the efficacy, safety and costs of hospital treatment with intravenous antibiotics and outpatient treatment with oral antibiotics. Seventy-six patients were included in the study. Forty-four of them underwent intravenous treatment with Metronidazole 500 mg/8 h + Ciprofloxacin 400 mg/12 h (hospital treatment group) and 32 took oral antibiotics Metronidazole 500 mg/8 h and Ciprofloxacin 500 mg/12 h (outpatient group). RESULTS: Outpatient treatment is viable in almost 95 % of those patients suffering from uncomplicated acute diverticulitis. Treatment was effective in resolving inflammation, and there were no complications in the majority of cases (94 %). Only 2 patients (6 %) required admission after outpatient treatment. The results further reflect complications and relapse rates similar to those of patients admitted to hospital and treated with intravenous antibiotics. There are no significant statistical differences (p = 0.86) between inpatients and outpatients. It is possible to save approximately 1,600 € per patient with outpatient treatment (p < 0.05). CONCLUSIONS: Outpatient treatment has demonstrated a safety and efficiency similar to inpatient treatment, producing an important reduction in expenses and medical resources.

Neuromodulación de raíces sacras como tratamiento de la incontinencia fecal. Resultados preliminares / Sacral root neuromodulation as treatment for fecal incontinence. Preliminary results

Presentamos nuestra experiencia inicial en el tratamiento de laincontinencia fecal (IF) mediante neuromodulación de raíces sacras(NRS), a través de los resultados de un estudio prospectivo realizadocon 26 pacientes en el que se comparan los valores basales enla escala de continencia de Wexner-Cleveland y en la capacidadpara el retraso de la defecación, con los obtenidos tras un año deterapia con NRS. El estudio inicial de cada paciente incluía anamnesis,exploración general, ecografía y manometría rectal, así comounos diarios de continencia y de calidad de vida específicos para laIF de 3 semanas. Antes de la terapia con NRS, el valor medio en laescala Wexner-Cleveland fue de 15,00 ± 1,81 y el 62,50% de lospacientes tenía una capacidad de retraso de la defecación menorde 1 minuto. Tras un año de terapia con NRS, el valor medio en laescala de Wexner-Cleveland fue de 4,87 ± 2,54 (p = 0,0031) y el75,01% de los pacientes presentaba una capacidad de retraso defecatoriomayor de 15 minutos (p = 0,0018). Hacemos, además,una descripción detalla de la técnica quirúrgica de la NRS, haciendoreferencia a sus indicaciones y finalizamos revisando las distintasopciones terapéuticas para la IF mostrando nuestro algoritmo terapéuticopara esta patología. La NRS es una técnica eficaz para eltratamiento de la IF en pacientes seleccionados que no han respondidoa tratamiento conservador, biofeedback o correcciones anatómicas(esfinteroplastia), con una mínima morbilidad y susceptible derealizarse en un programa de cirugía ambulatoria

We present our initial experience in the treatment of fecal incontinence (FI) with sacral root neuromodulation (SRN) by reporting the results of a prospective study with 26 patients where baselineWexner-Cleveland scale scores and ability to delay defecationwere compard to results after one year with SRN. The initial studyof patients included history taking, general examination, anal ultrasonography,and manometry, and a three-week diary of continenceand quality of life specific for FI was used. Before SRN themean baseline Wexner-Cleveland score was 15.00 ± 1.81, and62.50% of patients could only delay defecation for less than aminute. After a year with NRS the mean Wexner-Cleveland scorewas 4.87 ± 2.54 (p = 0.0031), and 75.01% of patients could delaydefecation above fifteen minutes (p = 0.0018). We also describethe surgical technique and its indications, and finally reviewthe various therapeutical options for FI and show our algorithmfor this condition. SRN is an effective technique for the treatmentof FI in properly selected patients with no response to medicaltherapies (including biofeedback) or anatomic correction (sphincteroplasty),with efficacy, little morbidity, and a short hospital stay

[Sacral root neuromodulation as treatment for fecal incontinence. Preliminary results]. / Neuromodulación de raíces sacras como tratamiento de la incontinencia fecal. Resultados preliminares.

We present our initial experience in the treatment of fecal incontinence (FI) with sacral root neuromodulation (SRN) by reporting the results of a prospective study with 26 patients where baseline Wexner-Cleveland scale scores and ability to delay defecation were compared to results after one year with SRN. The initial study of patients included history taking, general examination, anal ultrasonography, and manometry, and a three-week diary of continence and quality of life specific for FI was used. Before SRN the mean baseline Wexner-Cleveland score was 15.00 +/- 1.81, and 62.50% of patients could only delay defecation for less than a minute. After a year with NRS the mean Wexner-Cleveland score was 4.87 +/- 2.54 (p = 0.0031), and 75.01% of patients could delay defecation above fifteen minutes (p = 0.0018). We also describe the surgical technique and its indications, and finally review the various therapeutical options for FI and show our algorithm for this condition. SRN is an effective technique for the treatment of FI in properly selected patients with no response to medical therapies (including biofeedback) or anatomic correction (sphincteroplasty), with efficacy, little morbidity, and a short hospital stay.